Other Species / Isoforms
  CK2A2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y13-p
AGSRARVyAEVNsLR
0 200
CK2A2 (human) AGSRARVyAEVNsLR Y13-p
CK2A2 (mouse) AGSRARVYAEVNsLR Y13
CK2A2 (rat) AGSRARVYSEVNSLR Y13
S18-p
RVyAEVNsLRsREyW
0 13
CK2A2 (human) RVyAEVNsLRsREyW S18-p
CK2A2 (mouse) RVYAEVNsLRSREYW S18-p
CK2A2 (rat) RVYSEVNSLRSREYW S18
S21-p
AEVNsLRsREyWDYE
0 5
CK2A2 (human) AEVNsLRsREyWDYE S21-p
CK2A2 (mouse) AEVNsLRSREYWDYE S21
CK2A2 (rat) SEVNSLRSREYWDYE S21
Y24-p
NsLRsREyWDYEAHV
0 4
CK2A2 (human) NsLRsREyWDYEAHV Y24-p
CK2A2 (mouse) NsLRSREYWDYEAHV Y24
CK2A2 (rat) NSLRSREYWDYEAHV Y24
K50-ac
VRKLGRGkYSEVFEA
0 2
CK2A2 (human) VRKLGRGkYSEVFEA K50-ac
CK2A2 (mouse) VRKLGRGKYSEVFEA K50
CK2A2 (rat) VRKLGRGKYSEVFEA K50
K84-ub
KKIKREVkILENLrG
0 1
CK2A2 (human) KKIKREVkILENLrG K84-ub
CK2A2 (mouse) KKIKREVKILENLRG K84
CK2A2 (rat) KKIKREVKILENLRG K84
R90-m1
VkILENLrGGTNIIk
0 1
CK2A2 (human) VkILENLrGGTNIIk R90-m1
CK2A2 (mouse) VKILENLRGGTNIIK R90
CK2A2 (rat) VKILENLRGGTNIIK R90
K97-ac
rGGTNIIkLIDTVkD
0 1
CK2A2 (human) rGGTNIIkLIDTVkD K97-ac
CK2A2 (mouse) RGGTNIIKLIDTVKD K97
CK2A2 (rat) RGGTNIIKLIDTVKD K97
K103-sc
IkLIDTVkDPVSKTP
0 1
CK2A2 (human) IkLIDTVkDPVSKTP K103-sc
CK2A2 (mouse) IKLIDTVKDPVSKTP K103
CK2A2 (rat) IKLIDTVKDPVSKTP K103
Y116-p
TPALVFEyINNTDFK
0 1
CK2A2 (human) TPALVFEyINNTDFK Y116-p
CK2A2 (mouse) TPALVFEYINNTDFK Y116
CK2A2 (rat) TPALVFEYINNTDFK Y116
K159-ub
GIMHRDVkPHNVMID
0 1
CK2A2 (human) GIMHRDVkPHNVMID K159-ub
CK2A2 (mouse) GIMHRDVKPHNVMID K159
CK2A2 (rat) GIMHRDVKPHNVMID K159
S195-p
EYNVRVAsRYFKGPE
Upstream
0 7
Treatment
  • ischemia
CK2A2 (human) EYNVRVAsRYFKGPE S195-p
CK2A2 (mouse) EYNVRVAsRYFKGPE S195-p
CK2A2 (rat) EYNVRVASRYFKGPE S195
Y210-p
LLVDYQMyDYSLDMW
0 1
CK2A2 (human) LLVDYQMyDYSLDMW Y210-p
CK2A2 (mouse) LLVDYQMYDYSLDMW Y210
CK2A2 (rat) LLVDYQMYDYSLDMW Y210
Y240-p
FFHGQDNyDQLVRIA
0 2
CK2A2 (human) FFHGQDNyDQLVRIA Y240-p
CK2A2 (mouse) FFHGQDNYDQLVRIA Y240
CK2A2 (rat) FFHGQDNYDQLVRIA Y240
Y256-p
VLGTEELyGYLkkYH
1 1
CK2A2 (human) VLGTEELyGYLkkYH Y256-p
CK2A2 (mouse) VLGTDELYGYLkKYH Y256
CK2A2 (rat) VLGTDDLYGYLKKYH Y256
K260-ub
EELyGYLkkYHIDLD
0 4
CK2A2 (human) EELyGYLkkYHIDLD K260-ub
CK2A2 (mouse) DELYGYLkKYHIDLD K260-ub
CK2A2 (rat) DDLYGYLKKYHIDLD K260
K261-ub
ELyGYLkkYHIDLDP
0 1
CK2A2 (human) ELyGYLkkYHIDLDP K261-ub
CK2A2 (mouse) ELYGYLkKYHIDLDP K261
CK2A2 (rat) DLYGYLKKYHIDLDP K261
K280-ub
ILGQHSRkRWENFIH
0 1
CK2A2 (human) ILGQHSRkRWENFIH K280-ub
CK2A2 (mouse) ILGQHSRKRWENFIH K280
CK2A2 (rat) ILGQHSRKRWENFIH K280
S288-p
RWENFIHsENRHLVS
Upstream
0 4
Treatment
  • MG132_withdrawal
CK2A2 (human) RWENFIHsENRHLVS S288-p
CK2A2 (mouse) RWENFIHsENRHLVS S288-p
CK2A2 (rat) RWENFIHSENRHLVS S288
K304-ub
EALDLLDkLLRYDHQ
0 1
CK2A2 (human) EALDLLDkLLRYDHQ K304-ub
CK2A2 (mouse) EALDLLDKLLRYDHQ K304
CK2A2 (rat) EALDLLDKLLRYDHQ K304
K330-ub
PYFYPVVkEQsQPCA
0 3
CK2A2 (human) PYFYPVVkEQsQPCA K330-ub
CK2A2 (mouse) PYFYPVVkEQsQPCA K330-ub
CK2A2 (rat) PYFYPVVKEQSQPCA K330
S333-p
YPVVkEQsQPCADNA
0 2
CK2A2 (human) YPVVkEQsQPCADNA S333-p
CK2A2 (mouse) YPVVkEQsQPCAENT S333-p
CK2A2 (rat) YPVVKEQSQPCAENT S333
S343-p
CADNAVLsSGLTAAR
0 1
CK2A2 (human) CADNAVLsSGLTAAR S343-p
CK2A2 (mouse) CAENTVLSSGLtAAR S343
CK2A2 (rat) CAENTVLSSGLTAAR S343
T347
AVLsSGLTAAR____
0 1
CK2A2 (human) AVLsSGLTAAR____ T347
CK2A2 (mouse) TVLSSGLtAAR____ T347-gl
CK2A2 (rat) TVLSSGLTAAR____ T347
K103-ub
IkLIDTVkDPVSKTP
0 1
CK2A2 (human) IkLIDTVkDPVSKTP K103-ub
CK2A2 (mouse) IKLIDTVKDPVSKTP K103
CK2A2 (rat) IKLIDTVKDPVSKTP K103
K317-ub
HQQRLTAkEAMEHPY
0 1
CK2A2 (human) HQQRLTAkEAMEHPY K317-ub
CK2A2 (mouse) HQQRLTAKEAMEHPY K317
CK2A2 (rat) HQQRLTAKEAMEHPY K317